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Abstract
Rationale—The ventricular conduction system (VCS) rapidly propagates electrical impulses 
through the working myocardium of the ventricles to coordinate chamber contraction. Genome-
wide association studies (GWAS) have associated nucleotide polymorphisms, most are located 
within regulatory intergenic or intronic sequences, with variation in VCS function. Two highly 
correlated polymorphisms (r2>0.99) associated with VCS functional variation (rs13165478 and 
rs13185595) occur 5’ to the gene encoding the bHLH transcription factor HAND1.
Objective—Here, we test the hypothesis that these polymorphisms influence HAND1 
transcription thereby influencing VCS development and function.
Methods and Results—We employed transgenic mouse models to identify an enhancer that is 
sufficient for left ventricle (LV) cis-regulatory activity. Two evolutionarily conserved GATA 
transcription factor cis-binding elements within this enhancer are bound by GATA4 and are 
necessary for cis-regulatory activity, as shown by in vitro DNA binding assays. CRISPR/Cas9-
mediated deletion of this enhancer dramatically reduces Hand1 expression solely within the LV 
but does not phenocopy previously published mouse models of cardiac Hand1 loss-of-function. 
Electrophysiological and morphological analyses reveals that mice homozygous for this deleted 
enhancer display a morphologically abnormal VCS, and a conduction system phenotype consistent 
with right bundle branch block. Using 1000 Genomes Project data, we identify three additional 
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SNPs, located within the Hand1 LV enhancer, that compose a haplotype with rs13165478 and 
rs13185595. One of these SNPs, rs10054375, overlaps with a critical GATA cis-regulatory 
element within the Hand1 LV enhancer. This SNP, when tested in electrophoretic mobility shift 
assays (EMSA), disrupts GATA4 DNA-binding. Modeling two of these SNPs in mice causes 
diminished Hand1 expression and mice present with abnormal VCS function.
Conclusions—Together, these findings reveal that SNP rs10054375, which is located within a 
necessary and sufficient LV-specific Hand1 enhancer, exhibits reduces GATA DNA-binding in 




Arrhythmia; conduction system; cardiac development; transcription factors; genetics; 
Arrhythmias; Animal Models of Human Disease; Developmental Biology; Gene Expression and 
Regulation; Genetically Altered and Transgenic Models
INTRODUCTION
The cardiomyocytes that initiate and transmit the electrical impulses that drive coordinated 
heart contraction compose the cardiac conduction system (CCS). Within the ventricles, the 
ventricular conduction system (VCS) rapidly propagates these electrical impulses from the 
atrioventricular node to the ventricular apex to depolarize the working cardiomyocytes.1 The 
VCS, which consists of the His bundle, the left bundle branch (LBB), right bundle branch 
(RBB), and the Purkinje fiber (PF) network, is derived from trabecular myocardium and 
septum crest,.2 VCS disorders often manifest as arrhythmias.3 The genetic and 
developmental mechanisms that underlie arrhythmias are poorly understood. In humans, the 
QRS complex in a surface electrocardiogram (ECG) depicts VCS-mediated depolarization 
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of the ventricles.4 GWAS analyses have identified numerous QRS duration-associated single 
nucleotide polymorphisms (SNPs).5–8 The majority of these SNPs occur within intergenic or 
intronic sequences that are hypothesized to lie within regulatory DNA;9, 10 thereby 
impacting transcription and deleteriously influencing CCS development and/or function.
10, 11
Here, we identify a 336 bp evolutionarily conserved murine enhancer (Hand1LV), located 
~15Kb 5’ to the transcriptional start site of the gene encoding the bHLH transcription factor 
HAND1, that is necessary and sufficient to drive reporter gene expression specifically within 
the LV. In mice, HAND1 functions within the embryonic LV as the heart undergoes 
trabeculation.12 Conditional cardiac Hand1 ablation during embryogenesis leads to 
ventricular septal defects (VSDs) and hyperplastic atrioventricular valves.13 Although 
CRISPR/Cas9-mediated deletion of the Hand1LV enhancer dramatically reduces LV Hand1 
expression, it does not phenocopy the Hand1 cardiomyocyte-specific knockout phenotype. 
In humans, two highly correlated SNPs (r2>0.99) associated with QRS duration (rs13165478 
and rs13185595) flank the region syntenic to the Hand1LV enhancer.7 Individuals carrying 
the minor variant of rs13165478 exhibit a QRS interval shortening of approximately 1 ms.
7, 8, 14, 15 In mice, transgenic Hand1 overexpression within the adult myocardium causes 
QRS prolongation, a predisposition to ventricular arrhythmia, and elevated cardiac 
expression levels of the gap junction subunit CONNEXIN40 (encoded by Gja5).16 Given the 
proximity of these SNPs to the Hand1LV enhancer, and the potentially novel role for 
HAND1 in the cardiac conduction system, we hypothesized that these SNPs may influence 
the function of one or more essential Hand1 cis-regulatory elements within the Hand1LV 
enhancer. Mice homozygous for the Hand1LV enhancer deletion present with decreased LV 
Hand1 expression, a prolonged QRS interval, shortened PR interval, dysregulated LV gene 
expression, aberrant VCS development, and impaired CCS function. The Hand1LV enhancer 
contains two evolutionarily conserved GATA cis-regulatory elements, which are capable of 
GATA4 DNA-binding and are necessary for Hand1LV enhancer transcriptional activity. 
Using 1000 Genomes Project data, 17 we identified three additional SNPs located within the 
evolutionarily conserved Hand1LV enhancer, which are highly correlated with the QRS-
associated SNP rs13165478 (all r2>0.95 in both European and African ancestry 
populations). One of these novel SNPs, rs10054375, directly overlaps and alters sequence of 
the 3’ critical GATA cis-regulatory element within the Hand1LV enhancer resulting in a 
reduction of GATA4 DNA-binding affinity. Modeling two of the three novel SNPs, 
rs10076436 and rs10054375 in mice results in modest yet significant reduction of Hand1 LV 
expression accompanied by abnormal VCS function. Together, these findings reveal that 
SNP rs10054375 impedes efficient GATA DNA-binding within an LV-specific Hand1 
enhancer which is necessary and sufficient for normal VCS development and function in 
mice and potentially in humans.
METHODS
Data availability statement
All datasets featured within this manuscript will be made available from the corresponding 
author upon request.
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All sequences were obtained from Ensembl (http://www.ensembl.org) via BLASTN 
analyses using the mouse Hand1 sequence as a point of reference. Synteny to the Hand1 
locus was validated for all conserved non-coding sequences. mVISTA alignment, 
PATTERNMATCH and CLUSTALW analyses were performed on the following web sites: 
(http://genome.lbl.gov/vista/index.shtml and http://workbench.sdsc.edu).
Cloning
To generate Constructs #22, the putative Hand1 enhancer element was isolated from 
C57Bl/6 genomic DNA using the primers BoxA(F) 
TATCACGTGCCTAGCTGAGGGGACTCT and BoxA(R) 
CATATGTCGACTTGTCTCAATCCCCCT and cloned into the hsp68-lacZ expression 
construct.18 This sequence was subcloned using primers BoxAEMSA_01 and 
BoxAEMSA_04 RC (sequence below) to generate Constructs #23. All constructs were 
sequence validated.
To generate Construct #22.G1,2, point mutagenesis was performed using the QuikChange® 
Site-Directed Mutagenesis Kit (Stratagene) according to manufacturer’s instructions with 
the following primers and their reverse complements: H1BoxA[GATAmut1], 5’-
ACCCTTGTCTCTTCCACCTTCGCGAAGCCTCACACGTTTGGGG-3’; 
H1BoxA[GATAmut2], 5’-
AAACAGAGGCGGGTGGCATGCCACCATAGCCCCTTCTTGCC-3’. Mutagenized base 
pairs are in bold font.
Experimental mice
All transgenic mice were generated either by the Indiana University Transgenic and Knock-
Out Mouse Core or the University of Michigan Transgenic Animal Model Core. Genotyping 
of the Hand1tm1Eno, Cntn23’UTR-IRES-Cre-EGFP and Gt(ROSA)26Sortm1Sor alleles have been 
previously described.13, 19, 20 Yolk sac DNA was used to assess transgene integration using 
the primer pairs: lacZ(F), 5’-GATCCGCGCTGGCTACCGGC-3’ and lacZ(R), 5’-
GGATACTGACGAAACGCCTGCC-3’.
CRISPR/Cas9 deletion of the Hand1LV enhancer was performed by SAGE Labs, a Horizon 
Discovery Group Company. CRISPR/Cas9 generation of the Hand136,75 allele was 
performed by the Genome Engineering and iPSC Center at Washington University. Both 
alleles were generated and maintained on an FVB genetic background. For the Hand1ΔLV 
allele, the upstream and downstream gRNAs used were 5’-
ACTACGTATAGCTGAGACTATGG-3’ and 5’-GTGGAGAGTCCCCTCAGCTAGGG-3’, 
respectively. Pups and embryos were genotyped using the primers Hand1LV114(F), 5’-
GCTGTGTATTGTGATGGAGAGG-3’ and Hand1LV114(R), 5’-
CTTTTGACACAAAGGCTCCTG-3’, which generated an 854 bp wild-type amplicon, and a 
104 bp Hand1ΔLV amplicon.
For the Hand136,75 allele, the upstream and downstream gRNAs used were 
MS644.Hand1.sp22 5’-CCACCCGCCTCTGTTTCGTTNGG-3’ and MS644.Hand1.sp8 5’-
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CCAAACGAAACAGAGGCGGGNGG-3’. Pups and embryos were genotyped using the 
primers Hand1LV_dual_mod(F) 5’-ATCCCCACCCTTGTCTCTTC-3’, and 
Hand1LV_dual_mod(R), 5’-GGTGCAGAAACACGAGATCA-3’. Amplicons were digested 
with FokI, which generated an 351 bp wild-type amplicon, and 246 bp and 105 bp 
Hand136,75 amplicons. For both the Hand1ΔLV and Hand136,75 alleles, founder mice were 
bred with wild-type FVB mice to generate F1 mice. These F1 mice and intercrossed F2 mice 
were then intercrossed to generate F2 and F3 mutant mice and embryos for analysis. Both 
male and female embryos and pups were used for all analyses. All animal maintenance and 
procedures were performed in accordance with the Indiana University School of Medicine 
Animal Care and use committee.
X-gal staining
X-gal staining was performed as previously described. 21 If stained embryos were to be 
sectioned and immunohistochemically stained, they were fixed both pre- and post-staining in 
10% neutral buffered formalin, rather than, respectively, 2% 
paraformaldehyde-0.2%glutaraldehyde and 4% paraformaldehyde. P7 hearts were 
dehydrated in ethanol and cleared in a 1:1 mixture of methyl salicylate:benzyl benzoate.
Immunohistochemistry
Immunohistochemistry was performed as previously described.22 α-CNTN2 (R&D 
Systems, #AF4439) antibody was used at a dilution of 1:50. α-GJA5 (Boster Bio: PA1368) 
antibody was used at a dilution of 1:100. Primary antibodies were bound with biotinylated 
α-goat secondary antibody and SA-HRP (Vector Laboratories). HRP color reaction was 
developed using the DAB Peroxidase Substrate kit (Vector Laboratories) according to the 
manufacturer’s instructions. α-HCN4 (Merck Millipore: AB5808) rabbit polyclonal and α-
ACTC1 (Sigma: A9357) mouse monoclonal antibodies were diluted 1:200 and 1:400, 
respectively. Control immunohistochemistry lacking the addition of the primary antibody 
fail to produce immunodetection within CCS tissues (CNTN2, HCN4, CX40) or 
cardiomyocytes (ACTC1).
In situ hybridization
Whole mount in situ hybridization was performed as described.23 Antisense digoxygenin-
labeled Hand1 riboprobe was synthesized using T7, T3 or SP6 polymerases (Promega) and 
DIG-Labeling Mix (Roche) using a linearized plasmid template.
Immunohistochemical 3D reconstruction
3D reconstruction of HCN4 expression was performed as previously described.24 Briefly, P0 
hearts were sectioned at 10 μm, and each third section was immunohistochemically stained 
with antibodies against both HCN4 and ACTC1. Images of immunohistochemically stained 
sections were then captured with a Leica DM 6000 fluorescence microscope. The stacks of 
images were aligned in Amira and then labeled in the same program to render a 3D 
reconstruction.
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Electrophoretic Mobility Shift Assay (EMSA)
EMSAs were performed as previously described.25, 26 In vitro transcription and translation 
was performed using a pCS2-FLAG+Gata4 expression plasmids and the TnT rabbit 
reticulocyte lysate in vitro transcription system (Promega) as per manufacturer’s 
instructions. To generate whole cell lysates, HeLa cells were transfected using X-
tremeGENE HP transfection reagent (Roche) according to manufacturer’s instructions. Cells 
were harvested and lysed via sonication. The following oligos, which were annealed to their 
complements, were used to generate radiolabelled probes;
GATA 5’, 5’-ACCCTTGTCTCTTCCACCTTTATCAAGCCTCACACGTTTGGGG-3’; 
GATA 3’, 5’-AAACAGAGGCGGGTGGCAGATAACCATAGCCCCTTCTTGCC-3’; 
GATAmut 5’, 5’-ACCCTTGTCTCTTCCACCTTCGCGAAGCCTCACACGTTTGGGG-3’; 
GATAmut 3’, 5’-AAACAGAGGCGGGTGGCATGCCACCATAGCCCCTTCTTGCC-3’; 





Significance of QRTPCR results was determined by two tailed students T-test followed by 
post hoc Benjamini-Hochberg FDR correction that is automatically calculated by 
QuantStudio 3 qRTPCR thermal cycler software analysis package. ECG measurements were 
assessed under blinded conditions. For analyses of ECG parameters, the mean ± standard 
error was determined for the indicated number of mice assayed. Normal distribution of the 
data was determined by Shapiro-Wilk test. Significant variation among data sets fitting a 
normal distribution was then assessed using one-way ANOVA followed by Tukey’s test, for 
post hoc comparisons, as specified. For non-parametric comparison between 2 groups, the 
Mann-Whitney U test was employed. F0 transgenic reporter sets were compared via Fisher 
Exact Test (p ≤ 0.05). Box plots were generated using BoxPlotR (http://shiny.chemgrid.org/
boxplotr/). Center lines within the boxes indicate medians. The box limits represent the 25th 
and 75th percentiles. Whiskers represent 1.5X the interquartile range from the box limits and 
outliers are represented by open dots. Outliers are defined according to Tukey’s rule. Mann-
Whitney U tests were applied to all Optical mapping analysis.
Surface ECG
All mice in ECG studies were assayed at 5-weeks of age. Mice were anesthetized with 
isoflurane (2.5% vol vapor) and placed in a supine position on a heating pad. Body 
temperature was continuously monitored via a rectal thermistor and maintained between 37° 
and 38° Celsius. Platinum needle electrodes (Model F-E2, Grass Technologies, West 
Warwick, RI) were placed subcutaneously in the right and left axilla and in the left groin. 
Bipolar leads I, II, and III were sequentially recorded for 1 min each, using an isolated 
biological amplifier (ISO-Dam, World Precision Instruments, Inc. Sarasota, FL) with a high-
frequency filter of 1 kHz and 1,000-fold gain. The signal was fed into an analog-to-digital 
converter (DAQCard Al-16XE-50; National Instruments, Austin, TX), sampled with 2 kHz 
at 16-bit resolution, and displayed in real-time on the screen of a laptop computer by using a 
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custom-written data acquisition system implemented in Matlab (The Math Works, Natick, 
MA). ECG recordings were analyzed using the Clampfit module of the pClamp11 software 
(Molecular Devices, Sunnyvale, CA). A signal-averaged ECG was generated by overlaying 
all the cycles in a recording, using QRS maximum or QRS minimum for alignment. The PR-
interval was measured from the beginning of the P-wave to the beginning of the QRS 
complex. QRS duration was measured from the first deflection of the Q-wave (or R-wave in 
the absence of a Q-wave) to the nadir of the S-wave (defined as the point of minimum 
voltage in the terminal portion of the QRS complex; method I), and to the onset of the J 
wave (method II)27. The QT interval was defined as the interval from the beginning of the 
QRS complex to the end of the T-wave (defined as the point where the T-wave merges with 
the isoelectric line). The R-R interval was obtained as the average R-R interval over the 
sampling period.
Epicardial optical voltage mapping of Langendorff-perfused hearts
High-resolution optical mapping experiments were performed on 7- to 50-week-old 
Hand1LV mice, 7- to 15-week-old Hand136;75/36/75 mice, wild-type littermates, and 5 47-to 
70-week-old Hand136;75/36/75 mice and assayed as described.28 Hearts were isolated and 
retrogradely perfused in Langendorff-mode with temperature-controlled (37°C) Krebs-
Henseleit solution (pH 7.4 when gassed with a mixture of 95% O2 and 5% CO2) at an aortic 
pressure of 70 cm H2O. A volume-conducted ECG was monitored continuously throughout 
the experiment. After 10 minutes of stabilization, the hearts were stained with the voltage-
sensitive dye Di-4-ANEPPS (2 μL of a 2-mmol/L stock solution). The heart was then 
washed with dye-free solution for 5 min followed by the addition of (±)-blebbistatin to 
uncouple contraction from excitation (10 μmol/L; Tocris Bioscience, Minneapolis, MN). 
The stained hearts were illuminated with a laser at a 532 nm wavelength and the 
fluorescence was collected by a MiCAMUltima-L CMOS camera (SciMedia, Costa Mesa, 
CA) through a 715-nm long-pass filter. The fluorescence was recorded at a 1 ms/frame rate 
in a 100 ×100 pixel grid with a spatial resolution of 0.35×0.35 mm2 per pixel. Optical 
signals were processed with both spatial (3×3 pixels Gaussian filter) and temporal (3 frames 
moving average) filtering. Hearts were paced at the right atrium at a cycle length of 120 ms. 
Three 1-s recordings were captured sequentially while the right atrium was paced at cycle 
lengths of 120, 150 and 200 ms. This protocol was repeated once. Finally, three 1-s 
recordings were acquired while the hearts were paced from the apex at cycle lengths of 120, 
150 and 200 ms. Activation time was measured as described previously.28
Quantitative RT-PCR
Total RNA was isolated from E11.5 ventricles using the High Pure RNA Isolation Kit 
(Roche). This RNA was then used to synthesize cDNA using the High-Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems). For qRT-PCR, cDNA was amplified using 
TaqMan Probe-Based Gene Expression Assays (Applied Biosystems) and the QuantStudio 3 
Real-Time PCR System (ThermoFisher). Normalization to GAPDH was used to determine 
relative gene expression and statistical analysis automatically applied by the instrument 
software.
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A GATA-dependent distal Hand1 enhancer is necessary and sufficient for gene expression 
within the LV
To identify potential cis-regulatory elements controlling HAND1 LV transcription, we 
interrogated a 744 bp murine conserved non-coding sequence (CNS) that displays > 75% 
conservation between mammals and reptiles over 100 bp (Fig. 1A; red). We isolated this 
sequence, located at chr11:57660605–57661348 (mm9), and generated a β-galactosidase 
(lacZ) reporter construct (Fig. 1A; Construct #22). Of 12 transgenic E10.5 F0 embryos, 8 
displayed robust X-gal staining within the LV myocardium similar to Hand1lacZ knock-in 
mice21 (Fig. 1, compare 1B, E with C, F). We further refined the Hand1LV enhancer to the 5’ 
most 336 bp of this CNS (Fig. 1A; Construct #23), observing LV-specific X-gal staining, 
consistent with Hand1lacZ mice, in all 8 transgene-positive F0 embryos (Fig. 1D, G).
To identity evolutionarily conserved cis-elements that regulate Hand1LV enhancer activity, 
we employed phylogenetic footprinting. Comparison of the orthologous Hand1LV enhancer 
sequences in different species revealed two GATA cis-regulatory elements that are 
evolutionarily conserved. The 5’ GATA cis-element is conserved among mammals, and 3’ 
GATA cis-element is conserved through reptiles (Fig. 1A). Gene regulation within the 
developing ventricular myocardium involves GATA transcription factors.29, 30 Publicly 
available ChIP-Seq data sets indicate that GATA4 occupies the Hand1LV enhancer within 
cardiomyocyte progenitor cells (Online Fig. I). Electro Mobility Shift Assay (EMSA) 
confirms specific GATA4 DNA-binding to both GATA cis-element sequences (Fig. 1H, 
arrowhead). Additionally, a 10-fold excess of unlabeled competitor oligo (WT) reduces 
binding to the labeled probe; however, addition of an unlabeled competitor oligo in which 
the GATA cis-regulatory element is mutagenized (mut) does not effectively compete for 
GATA4 DNA binding (Fig. 1H).
We next assessed whether these GATA cis-elements are necessary for Hand1LV activity in 
vivo. We generated point mutants in the GATA elements within Construct #22 (Construct 
#22.G1,2; Fig. 1A). None of the 5 transgenic E10.5 F0 embryos generated with Construct 
#22.G1,2 exhibited LV X-gal staining (Fig. 1I, J; p = 0.029 compared to Construct #22 
transgenics, Fisher Exact Test). We conclude that the conserved GATA cis-binding elements 
within the minimal Hand1 enhancer are necessary for LV transcription.
To validate that the Hand1LV enhancer is necessary for myocardial Hand1 expression and 
LV development, we employed CRISPR/Cas9 to delete the genomic region containing this 
enhancer (Fig. 2A). Two independent F0 founders were identified. The line containing the 
smaller 750 bp deletion of Hand1LV, we termed Hand1ΔLV. This deletion encompasses all 
but 4 bp on the 5’ end of the 744 bp fragment included in Construct #22, as well as an 
additional 10 bp on the 3’ end. We generated Hand1ΔLV/ΔLV mutants at E10.5 to test whether 
in vivo Hand1LV deletion disrupts Hand1 LV gene expression. Whole mount Hand1 in situ 
hybridization reveals a marked reduction of LV Hand1 expression within Hand1ΔLV/ΔLV 
embryonic hearts (compare Fig. 2B, C, arrowheads). Hand1 expression within the cardiac 
outflow tract (OFT) and lateral mesoderm (LM) is unaffected. Next, E11.5 ventricles 
isolated from Hand1ΔLV/ΔLV and Hand1+/+ littermates were subjected to qRT-PCR using 
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Taqman primers specific for Hand1 (Fig. 2D). Consistent with in situ hybridization findings, 
Hand1 RNA levels are markedly reduced to roughly 20% of its normal levels in 
Hand1ΔLV/ΔLV mutants. Expression of the putative upstream Hand1 transcriptional regulator, 
Gata4, was unchanged (Fig. 2D). Additionally, the expression of evolutionarily conserved 
genes located within 0.5 Mb upstream and downstream of Hand1 are unaltered in E11.5 
ventricles of Hand1ΔLV/ΔLV mutants (Online Fig. II). These findings demonstrate that 
deletion of Hand1LV specifically reduces LV Hand1 expression and does not impact the 
expression of neighboring genes or any Hand1 expression domains outside the LV at mid-
gestation.
Hand1ΔLV/ΔLV mice display abnormal VCS gene regulation, function, and development
We then assessed whether Hand1ΔLV/ΔLV mutants display changes in cardiac gene 
expression similar to what is observed in HAND1 loss-of-function.13 Conditional 
inactivation of Hand1 within the embryonic heart downregulates LV expression of the 
transcriptional co-activator Cited1.13 qRT-PCR reveals that Cited1 expression is likewise 
significantly downregulated in Hand1ΔLV/ΔLV E11.5 mutant ventricles (Fig. 2D). Hand1 
loss- or gain-of-function is associated with altered expression of the VCS marker Gja5.13, 16 
qRT-PCR shows that expression of Gja5 is significantly downregulated within E11.5 
Hand1ΔLV/ΔLV ventricles (Fig. 2D). Together, these findings demonstrate that deletion of the 
Hand1LV alters normal E11.5 expression of HAND1 downstream targets.
In contrast to the high penetrance neonatal lethality observed in cardiomyocyte HAND1 
loss-of-function,13 we observed that Hand1ΔLV/ΔLV mice are viable and fertile (Online Table 
I). Although histological analyses at E17.5 reveal that roughly 1 of 6 Hand1ΔLV/ΔLV mutant 
hearts present with a VSD, we observe no neonatal or embryonic lethality in Hand1ΔLV/ΔLV 
mice. The presence of VSDs is consistent with both the conditional myocardial Hand1 13 
and conditional LV Hand1 knockouts.12 The penetrance; however is markedly reduced 
within Hand1ΔLV/ΔLV mutants. Also in contrast to both the myocardial and LV Hand1 
conditional knockouts, the LV free wall of Hand1ΔLV/ΔLV mutants is not grossly 
dysmorphic. Thus, homozygosity of the Hand1ΔLV allele does not impart significant 
lethality.
In humans, the conserved HAND1LV enhancer is located in between two QRS interval–
associated SNPs, rs13165478 and rs13185595. We therefore examined whether reduced 
embryonic Hand1 LV expression alters postnatal cardiac electrical function. ECG recordings 
in anesthetized 5-week-old Hand1ΔLV/ΔLV mice reveal significantly shortened PR intervals 
and prolonged QRS intervals when compared to both Hand1+/+ and Hand1+/ΔLV littermates 
(Fig. 3A–C and Online Table II). RR and QT intervals were not significantly affected (Fig. 
3D and Online Table II). These results are largely consistent with observations in humans 
where SNP rs13165478 has been associated with a shorter PR interval, in addition to its 
association with QRS interval, although this association is not at genome-wide 
significance31 (P=0.003).
In contrast to human ECGs, in which the QRS complex represents the depolarization of the 
ventricles, the mouse QRS complex represents both ventricular depolarization and 
repolarization.27 QRS prolongation in 5-week-old Hand1ΔLV/ΔLV mice indicates impaired 
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electrical activation of the ventricles, but extrapolating this to human data is a challenge. To 
determine ventricular activation patterns, we next performed optical voltage mapping of 
isolated perfused hearts from Hand1+/+ and Hand1ΔLV/ΔLV mice between 7 and 50 weeks of 
age. Representative colored activation maps obtained from the anterior ventricular surface 
are shown in Figure 3. During atrial pacing (Fig. 3E), Hand1+/+ hearts show two quasi-
simultaneous epicardial breakthroughs close to the apices of the LV and right ventricle (RV; 
denoted as 1 and 2 in Fig. 3F, Online Movie 1). These breakthroughs form wave fronts that 
fully activate the field of view within an average of 4.8 ms (Fig. 3H). Within roughly half 
(7/15) of atrial paced Hand1ΔLV/ΔLV hearts, singular breakthroughs near the LV apex are 
observed at all three pacing cycle lengths tested (120, 150 and 200 ms) and this is observed 
in both young and old adults (Fig. 3G; Online Movie 2). An additional four Hand1ΔLV/ΔLV 
hearts, rather than exhibiting quasi-synchronous LV and RV epicardial breakthroughs, 
displayed a second, delayed (>2 ms later) epicardial breakthrough proximal to the RV apex 
(Online Movie 3). This delayed breakthrough phenotype is observed in both young and old 
adults (Online Fig. III). We also observe two Hand1ΔLV/ΔLV hearts that exhibited a second, 
ectopic breakthrough near the base of the LV (Online Movie 4), and one heart that presented 
with a total of three breakthroughs – two proximal to the apex of the LV, and one near the 
apex of the RV (Online Movie 5). Given the rarity of these observations, we cannot account 
for any possible age correlations (Online Fig. III). The ventricular activation sequence of the 
one atrial paced Hand1ΔLV/ΔLV heart is indistinguishable from activation sequences observed 
in Hand1+/+ hearts (Online Movie 5; summarized in Table 1). Wave fronts emanating from 
breakthroughs in Hand1ΔLV/ΔLV hearts activated the field of view within 7.2 ms on average; 
significantly longer than Hand1+/+ hearts (Fig. 3H). Given that the PR interval is shortened 
in Hand1ΔLV/ΔLV mutants, we hypothesized that conduction from the atria to the ventricles is 
affected in these mutants. We measured the time elapsed from the epicardial activation of the 
right atrium (RA) to the LV breakthrough, observing similar durations at all cycle lengths 
tested (Online Fig. IV A–D). Epicardial breakthrough in the RV, relative to the LV, is 
significantly delayed in Hand1ΔLV/ΔLV mutants at cycle lengths of 120 and 150 ms (Fig. 3I, 
p=0.029 120 ms; Online Fig. IV: p=0.029, 120 ms; p=0.0122, 150 ms). Apical pacing (Fig. 
3J), which propagates an electrical signal through both the working myocardium and the 
Purkinje network, resulted in similar epicardial activation patterns and activation times in 
both Hand1+/+ and Hand1ΔLV/ΔLV hearts (Fig. 3K–M; Online Movies 6 and 7). Optical 
mapping of mutants homozygous for a second, independent Hand1ΔLV allele, in which 823 
bp overlapping Hand1LV has been deleted (termed Hand1ΔLV106), also reveals similar 
aberrant activation patterns when atrial paced (n = 3, Table 1). No functional evidence for 
the existence of atrioventricular accessory pathways could be demonstrated with 
decremental atrial or ventricular pacing (Online. Fig. IV B–D). Collectively, these findings 
indicate that conduction across the right VCS is impeded in Hand1ΔLV/ΔLV mutants, despite 
the fact that Hand1LV drives expression only within the LV. Further, the results suggest that 
the modest PR interval shortening seen in Hand1ΔLV/ΔLV mutants in vivo is due to enhanced 
atrioventricular nodal conduction rather than an atrioventricular bypass tract (Online Fig. IV 
B–D).
Suspecting VCS phenotypes congenitally derived from embryonic Hand1 function,21, 32 we 
assessed conduction system morphology in Hand1ΔLV/ΔLV mutants. Whole mount X-gal 
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staining from the Hand1lacZ allele21 shows that Hand1lacZ expression is detectable within 
the postnatal (P42) VCS. Immunohistochemistry showed clear overlap between Hand1-
driven X-gal stain and GJA5 immunoreactivity (Online Fig. V) confirming Hand1 
expression within the adult VCS. Breeding the Hand1ΔLV allele onto the Hand1lacZ 
knockout allele (Hand1ΔLV/lacZ) did not decrease postnatal survival (Online Table I). 
However, comparison of X-gal stained Hand1+/lacZ and Hand1ΔLV/lacZ hearts revealed an 
increase in staining along the LV septal wall of Hand1ΔLV/lacZ hearts (Fig. 4A, B arrows), 
suggesting that the Hand1ΔLV/ΔLV LV VCS may be hyperplastic. To test this, Hand1+/lacZ 
and Hand1ΔLV/lacZ hearts were stained for both X-gal and immunoreactivity of the CCS 
marker CONTACTIN2 (CNTN2).33 Hand1lacZ and CNTN2 double-positive cells are 
observed within the left His bundle (Fig. 4C, D, arrowheads) and the LBB (arrow; Fig. 4D). 
Hand1lacZ-positive cell localization further reveals that, in Hand1ΔLV/lacZ hearts, the cells on 
the left side of the His bundle appear abnormally dispersed (arrowheads, Fig. 4D), and the 
LBB appears hyperplastic (Fig. 4D, arrows).
To confirm the dysmorphic VCS phenotype, Hand1ΔLV/ΔLV mutants were bred onto mice 
heterozygous for the postnatal CCS-specific Cre driver, Cntn2IRES-Cre19 and the R26RlacZ 
reporter allele. P7 hearts were X-gal stained and cleared. Compared to Hand1+/+ and 
Hand1+/ΔLV;Cntn2+/IRES-Cre;R26R+/lacZ controls, Hand1ΔLV/ΔLV;Cntn2+/IRES-Cre;R26R+/lacZ 
visual observation of hearts reveals a hyperplastic His bundle, and a significantly broader 
more robust X-gal-positive staining domain overlapping with the LBB (Fig. 5A–C, 
arrowhead and arrow, respectively; n = 6). These data support that the left side of the 
Hand1ΔLV/ΔLV VCS is dysmorphic and hyperplastic. Additional staining of P42 hearts 
support that, not only is the left side of the VCS hyperplastic, (observed in 4 out of 5 hearts), 
Fig. 5D, E), the peripheral portions of the RBB network (white arrowheads) appear more 
compacted, and the proximal portions (white arrows) more diffuse, with more observed x-
gal stained fascicles than Hand1+/+ controls (observed in 3out of 5 hearts), Fig. 5F, G). To 
examine the His bundle and LBB in greater detail, immunohistochemistry for the potassium/
sodium channel HCN4 was performed upon sections of P0 Hand1+/+ and Hand1ΔLV/ΔLV 
hearts, which were then reconstructed in three dimensions (Fig. 5H–K). In 2 of 3 
Hand1ΔLV/ΔLV hearts examined, the left sided ventricular septum is malformed, with 1 
mutant displaying a membranous VSD and 1 displaying an aberrant canal that invades the 
membranous septum (Fig. 5I). All three Hand1ΔLV/ΔLV mutants displayed abnormally 
dispersed, hyperplastic His bundles and LBBs when compared to Hand1+/+ controls (Fig. 5I, 
K).
Polymorphisms within the human HAND1LV enhancer are associated with QRS duration
The Hand1ΔLV phenotype supports that functional variation within the syntenic HAND1 
enhancer may contribute to altered QRS duration in humans. However, SNPs rs13165478 
and rs13185595 are located 5’ and 3’ respectively of the putative human HAND1LV 
(schematized in Fig. 6A). Moreover, rs13165478 and rs13185595 are not conserved in 
mouse. We therefore looked for additional genomic variants occurring between rs13165478 
and rs13185595, ideally within Hand1LV, that are also associated with altered QRS duration. 
Three additional HAND1 SNPs occur in virtually perfect LD (r2>0.99) with rs13165478 
(Table 2). Two SNPs within this haplotype, rs10076436 and rs10054375, are directly located 
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within the Hand1LV sequence (Fig. 6A). Intriguingly, SNP rs10054375 alters the sequence 
of the necessary 3’- GATA cis-element binding site. We employed EMSA to assess whether 
these two SNPs influence GATA-factor DNA binding to HAND1LV. Oligos mimicking the 
minor variant of SNP rs10054375 are not bound as robustly by GATA4 (Fig. 6B) and, when 
used as an unlabeled DNA competitor, do not compete with GATA4 binding to the major 
variant as efficiently (Online Fig. VI). These data suggest that the minor variant of SNP 
rs10054375 is a weak GATA-factor binding site, and this mutation may decrease 
transcriptional output of HAND1LV.
To test this hypothesis, we employed CRISPR/Cas9 to generate mice harboring the minor 
variants of the QRS duration-associated SNPs rs10076436 and rs10054375 (the Hand136;75 
allele; Fig. 6C). qRT-PCR of E11.5 Hand136;75/36;75 mutant ventricles revealed a modest but 
significant (~20%) reduction in Hand1 expression (Fig. 6D). ECGs performed on 5-week-
old anesthetized Hand136;75/36;75 mice revealed no significant changes in PR, QRS, or QT 
interval when compared to Hand1+/+ or Hand1+/36;75 mice (Online Table II). However, 
epicardial activation maps obtained from 6 atrial paced hearts ranging between 7- and 15-
weeks of age reveal a single breakthrough site on the anterior RV free wall in one 
Hand136;75/36;75 heart (Fig. 6F; Online Movie 8), and three epicardial breakthroughs, one 
proximal to the apex of the RV and two proximal to the apex of the LV, in another heart (Fig. 
6G; Online Movie 9). Identical activation patterns were observed at cycle lengths of 120, 
150 and 200 ms. The remaining four Hand136;75/36;75 mutant hearts display activation 
patterns indistinguishable from Hand1+/+ controls (Fig. 6E; Online Movie 10). Suspecting 
that age could be a contributing factor given the low penetrance observed between 7 and 15 
weeks, we next assayed five hearts isolated from older Hand136;75/36;75 mutants – between 
46- and 70-weeks of age. All hearts assayed displayed aberrant activation maps. (Fig 6K–T) 
One Hand136;75/36;75 heart exhibited two breakthrough points in the LV (Fig. 6K; Online 
Movie 13). Two others exhibited a late (> 2 ms) breakthrough point within the RV (Fig. 6L, 
M; Online Movies 14 and 15), phenotypes consistent with those observed in Hand1ΔLV/ΔLV 
mutant hearts. The remaining two Hand136;75/36;75 hearts displayed, respectively, two 
breakthroughs within the RV, one proximal to the apex and one diffuse and displaced toward 
the base (Fig. 6N; Online Movies 16) and a diffuse RV breakthrough misplaced toward the 
base (Fig. 6O; Online Movies 17). The average time elapsed from the initiation of the wave 
front at the breakthrough site to activation of the ventricular base was not different among 
atrial paced Hand1+/+ and Hand136;75/36;75 hearts, nor did we find a significant difference in 
the epicardial conduction time during ventricular pacing from the apex (Fig. 6H–J, P-T; 
compare Online Movies 11 and 12). To look for morphological differences within the 
Hand136;75/36;75 VCS, we X-gal stained P42 Hand136;75/36;75;Cntn2+/IRES-Cre;R26R+/lacZ 
hearts and compared them to Hand1+/+;Cntn2+/IRES-Cre;R26R+/lacZ controls (n = 5, Online 
Fig. VII). We observe no differences in VCS morphology. To validate that the 
Hand136;75/36;75 heart phenotypes are significant when compared to controls, a p-value of 
0.001 was obtained using a Fisher exact test. We therefore conclude that the minor variants 
of SNPs rs10076436 and rs10054375 significantly affect Hand1LV transcriptional output. 
Although this modest level of regulation is not sufficient to alter CCS morphology, 
Hand136;75/36;75 hearts display defects in VCS function.
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Abnormal cardiac conduction can lead to sudden death and is a challenging clinical 
problem. The origin of conduction defects is broad and GWAS studies have identified 
hundreds of loci associated with cardiac conduction.7, 8, 14, 15 The majority of conduction-
associated SNPs occur within intronic or intergenic sequences suggesting a transcriptional 
regulation mechanism for these non-coding SNPs. Refined GWAS analyses has localized 
QRS- and QT-associated SNPs within putative enhancers.10 The goal of these human 
genetics studies is to functionally characterize these SNPs within the context of gene 
regulatory elements, and to define how these SNPs impact development and/or physiology, 
and thereby contribute to complex human traits. Here, we identify an evolutionarily 
conserved LV-specific HAND1 enhancer located between two intergenic SNPs that are 
associated with altered QRS duration.7, 8, 14, 15 In mice, Hand1LV is necessary (Fig. 2) and 
sufficient (Fig. 1) to drive LV-specific gene expression. Two GATA cis-elements directly 
regulate this enhancer. Hand1ΔLV/ΔLV mice are viable but exhibit both altered LV gene 
expression and display a morphologically abnormal VCS (Fig. 5). Hand1ΔLV/ΔLV mice also 
show a significantly broadened QRS interval, shortened PR interval, and 14 out of 15 
Hand1ΔLV/ΔLV mutant hearts assayed display altered ventricular activation patterns (Fig. 3). 
Humans carrying the minor variant of rs13165478 exhibit a roughly 1 ms shortening of the 
QRS interval, as well as a shortened PR interval that is not significant genome-wide.
7, 8, 14, 15 The additional SNP rs10054375 located within the HAND1LV directly changes a 
necessary GATA cis-element sequence and reduces GATA4 DNA-binding (Fig. 5). This 
reduced GATA DNA binding within the HAND1LV lowers Hand1 transcriptional activity, 
reducing Hand1 expression levels.
Variations within the HAND1LV enhancer are associated with QRS interval shortening in 
humans. Here we show that deletion of the Hand1LV enhancer results in QRS interval 
broadening in mice. Indeed, recapitulating the human SNPs in mice results in a QRS pattern 
indistinguishable from controls. The lack of observable ECG phenotype in the 
Hand136;75/36;75 mice may reflect subtle differences in GATA regulation of Hand1 
expression between mice and humans as well as the differences in the physiology of the two 
species. For example, in humans, QRS represents the depolarization phase of the ventricles 
whereas in mice it represents both ventricular repolarization and depolarization making 
understanding of changes to QRS complex between mice and humans a challenge.27 
Moreover, the Hand1ΔLV/ΔLV mice delete the entire Hand1LV enhancer, and are therefore 
likely not an appropriate comparison to humans, in which the majority of the HAND1LV 
enhancer is unaltered. These data, taken in total, do provide evidence that human subjects 
that carry the minor rs10054375 SNP, likely exhibit reduced GATA DNA binding to the 3’ 
most GATA site, and by consequence, reduced HAND1 expression. Subjects that carry this 
HAND1 minor allele may be susceptible to variation in VCS development in utero that 
could in part explain the shortened QRS duration with which this allele is associated.
Although we did not identify the etiology of the PR interval shortening observed in 
Hand1ΔLV/ΔLV mice, the results of the present study are most consistent with enhanced atrio-
ventricular conduction along the physiological anatomical pathway, most notably the 
defective His bundle morphology. The absence of accelerated atrioventricular conduction in 
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ex vivo Hand1ΔLV/ΔLV hearts (Online Fig. IV B–D) suggests that the PR shortening in vivo 
results from functional (e.g., autonomic influences), rather than structural, differences 
between genotypes. However, whether and how His bundle hyperplasia as seen in 
Hand1ΔLV/ΔLV hearts also contributes to enhanced atrioventricular condition remains to be 
determined.
The congenital origins of the VCS are found within the complex cell specification, 
differentiation, and morphological patterning gene regulatory networks that drive 
cardiogenesis. In the mouse, Hand1 LV expression is first detectable at E8.5 34 peaking 
between 9.5–10.5.35–37 Hand1 expression subsequently restricts and becomes undetectable 
by in situ hybridization by E13.5. Interestingly, Gja5 and Hcn4, two genes mis-regulated in 
Hand1ΔLV/ΔLV hearts, are essential for normal VCS function. Both Gja5 and Hcn4 show 
expression within the entire LV at E10.5 and, as the heart develops, restrict to the maturing 
VCS. Previous reports have shown Hand1 expression in the adult heart in rodents by PCR38 
and humans (GTEx Analysis Release V7, dbGaP Accession phs000424.v7.p2). Our X-gal 
staining shows that Hand1 transcriptional elements mark the His bundle, LBB, and left PF 
networks, co-localized with GJA5 and CNTN2 (Online Fig. V and Fig. 4C, D). Postnatally, 
Gja5 expression marks the VCS; however, at E9.5, Gja5 is expressed transmurally, and at 
E11.5 Gja5-negative cardiomyocytes expand the compact myocardium of the free wall. 
After birth, the trabecular zone remodels into the definitive VCS.4 In addition to its role in 
VCS development, reported here, HAND1 has been shown to play a role in ventricular 
cardiomyocyte identity.12 Our data supports a model in which the Hand1LV enhancer drives 
gene expression within embryonic trabecular myocytes. Function of this enhancer is affected 
by a SNP associated with an overlapping GATA cis-binding element. HAND1 appears to 
suppress the differentiation of embryonic myocytes into the conduction lineage. 
Additionally, HAND1 may transcriptionally regulate factors that control the intrinsic 
electrophysiological properties of conduction cells or their electrical continuity with 
working cardiomyocytes and describing these gene regulatory networks will be the subject 
of ongoing studies.
The mature VCS is morphologically asymmetrical, indicating that chamber-specific gene 
regulatory networks are integral to its normal development.1 Hand1 expression is restricted 
to the developing LV. Unexpectedly, Hand1LV deletion generates a cardiac phenotype 
consistent with RBB block. Given that the RV breakthroughs in Hand1ΔLV/ΔLV hearts are 
always focused and concentric, the RBB phenotype in these mutants most likely results from 
localized defects that derive from the malformed His bundle disrupting patent connection 
with the proximal portion of right VCS. We feel this is the most likely mechanism rather 
than one in which a diffuse deceleration within the RBB and/or right peripheral Purkinje 
cells that would impact Purkinje – myocyte coupling for two reasons. First, Hand1 
expression is detectable at the base of the RV septal wall (Online Fig. V B), and within the 
His bundle, which is malformed in Hand1ΔLV/ΔLV hearts (Fig. 5). Neither Hand1 expression 
nor Hand1-lineage 34 marks the right VCS. Second, an apically paced action potential 
propagates through both the working myocardium and the conduction system (Fig. 3K; Fig. 
6H; Online Movies 6 and 12). If Purkinje fiber coupling to the working myocardium were 
asymmetrically impaired in Hand1 mutants, then this action potential would not propagate at 
the same rate across both the left and right ventricles, as we have observed in all Hand1 
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mutant models assayed (Fig. 3L; Fig. 6I, J; Online Movies 7 and 11). Therefore, a model in 
which variation in Purkinje cell number and/or diminished Purkinje cell coupling to working 
myocardium causes variation in QRS interval is less likely although possible. Nevertheless, 
a causal link between VCS gene expression, morphology, and function in Hand1ΔLV/ΔLV 
hearts remains obscure, and will be the subject of further study.
Hand136;75/36;75 mutants only show a 20% reduction in Hand1 mRNA. Yet, surprisingly, this 
modest reduction may be sufficient to cause VCS phenotypes as two of six mutants exhibit 
VCS abnormalities (Fig. 6E–J); however, in older Hand136;75/36;75 mutant hearts VCS 
phenotypes are observed in all five mice tested (Fig. 6K–T). This may indicate that aging 
plays an important role in the SNP mediated defects and further studies of this are planned. 
The variations in the VCS phenotypes observed between the Hand136;75/36;75 and 
Hand1ΔLV/ΔLV mutants is likely influenced by the level of Hand1 message expressed within 
each model. Transcription factors that can bind and influence expression of the Hand1 minor 
variant, such as the 5’ GATA cis-element still present within the Hand136;75/36;75 mice, 
likely account for the variation in severity between the Hand1 mutant VCS phenotypes. 
Indeed, HAND1 SNPs associated with altered QRS duration do show evidence of genetic 
heterogeneity7, 8, 14, 15 and identifying modifier genes that influence HAND1-mediated VCS 
morphogenesis will be of importance to better define the gene regulatory networks that drive 
VCS formation in mammals.
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Nonstandard Abbreviations and Acronyms
bHLH basic helix–loop–helix
CCS cardiac conduction system
CNS conserved non-coding sequence
E embryonic day
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EMSA electrophoretic mobility shift assay
GWAS genome-wide association study





RBB right bundle branch
RV right ventricle
SNP single nucleotide polymorphism
VCS ventricular conduction system
VSD ventricular septal defect
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• Ventricular Conduction System (VCS) disorders often manifest as 
arrhythmias; however, the genetic and developmental mechanisms that 
underlie VCS disfunction are not well understood.
• A large number of Single Nucleotide Polymorphisms (SNPs) are associated 
with VCS variation but SNPs located outside of protein coding domains often 
provide no mechanistic insight.
• SNPs located 5’ to the gene encoding the basic Helix-loop-Helix (bHLH) 
transcription factor HAND1 are associated with variation in ventricular 
conduction in Hispanic, African American and European populations.
What New Information Does This Article Contribute?
• Located between these HAND1 SNPs, we identify a GATA-dependent Hand1 
left ventricular enhancer (LV) that is necessary and sufficient for Hand1 LV 
expression.
• We identify additional SNPs associated with VCS function, one within a 
necessary GATA DNA-binding site.
• Deletion of the Hand1 LV enhancer or incorporation of the SNP sequences 
that alter this GATA DNA binding site in mice results in decreased Hand1 
expression, altered VCS morphology, and defective VCS function.
Arrhythmias are a predictor of cardiac arrest and death. Two SNPs associated with VCS 
functional variation are located 5’ of the coding region of HAND1. These SNPs flank an 
evolutionarily-conserved non-coding sequence that is necessary and sufficient for Hand1 
expression within the embryonic LV. Two highly conserved GATA DNA binding sites are 
required for this LV-specific expression. Further analysis shows that an additional 
unreported SNP in near perfect linkage disequilibrium with the flanking SNPs alters one 
of the GATA DNA binding sites in a way that diminishes GATA factor DNA binding. 
Deletion of this LV-specific Hand1 enhancer or incorporation of the minor human SNP 
variants into the murine Hand1 locus produce adult mice that exhibit hypertrophic VCS 
structures as well as abnormal VCS function. These findings show a rare and important 
validation of genome wide association analysis as an approach to identify causes of 
cardiac disease and identify HAND1 as a critical transcription factor necessary for the 
formation and function of the cardiac conduction system. This new understanding of 
HAND1 during VCS formation and function allows for specific evaluation of the 
HAND1 dependent VCS gene regulatory network which will provide mechanistic insight 
into the etiology of arrythmias.
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Figure 1. A GATA-dependent Hand1 enhancer is sufficient to drive LV-specific gene expression.
A) Schematic representation of the mouse Hand1 locus, including the two conserved GATA 
cis-elements (green), and hsp68-lacZ reporter constructs. Exons and conserved non-coding 
sequence are highlighted in grey and red, respectively. Position, in Kb, relative to the Hand1 
transcription start site is noted. Positive transgenic expressers within the LV, and the total 
number of transgenic embryos examined are indicated. B-G) Whole mount (B-D) and 
transverse sections (E-G) of X-gal-stained E10.5 F0 embryos showing robust transgene 
expression in the LV (arrowhead), but not the neural crest cells (white arrow) or myocardial 
cuff (black arrow) of the outflow tract, of transient transgenics expressing Constructs #22 
(C, F) and #23 (D, G). An E10.5 Hand1lacZ/+ embryo is included for comparison (B, E). LV 
– left ventricle, RV – right ventricle. H) EMSA using lysate programmed with FLAG
+GATA4 demonstrates GATA4 binding (arrowhead) to radiolabeled oligonucleotides 
mimicking the two GATA consensus sites (GATA 5’ and GATA 3’) in the Hand1 LV 
enhancer. Western blots for α-FLAG (inset) verifies synthesis of FLAG-GATA4 that was 
added equally to each EMSA where indicated. I, J) A representative X-gal-stained E10.5 F0 
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embryo positive for Construct #22.G1,2 showing a lack of transgene expression in the LV 
(arrowheads). All Scale bars = 200 μM. n reflects biological replicates in transgenic analysis.
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Figure 2. The Hand1LV enhancer is necessary for LV gene expression of Hand1 and its 
downstream targets.
A) Schematic representation of the mouse Hand1 locus, and the CRISPR/Cas9-generated 
Hand1ΔLV allele. Exons and conserved non-coding sequence are highlighted in grey and 
orange, respectively. gRNA locations are shown in green. Arrowheads depict genotyping 
primers. B, C) Whole mount in situ hybridization shows a marked reduction in Hand1 
expression within the LV of Hand1ΔLV/ΔLV mutant embryos (white arrowheads). LM, lateral 
mesoderm; OFT, outflow tract. D) qRT-PCR of isolated E11.5 ventricles reveal diminished 
Hand1 (# p=6.4X10−06) and Hand1 downstream target genes Cited1 (# p=2.02X10−04) and 
Gaj5 (# p=2.02X10−04) between Hand1ΔLV/ΔLV mutants (n=6) and wild-type controls (n = 
4). Gata4 expression is unaffected (P=0.142). Significance changes in mRNA levels were 
calculated using a two-tailed students T-test with a post hoc Benjamini-Hochberg false 
discovery rate (FDR). Scale bars = 200 μM. Sample sizes indicates biological replicates.
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Figure 3. VCS function is abnormal in Hand1ΔLV/ΔLV mutants.
A) Representative lead II ECG tracings show prolonged QRS in Hand1ΔLV/ΔLV mutants 
(blue) compared to Hand1+/+ controls (red) at P35. B-D) Lead II ECG analyses confirm that 
PR interval (B) is shortened (p=0.041) and QRS duration (C) is prolonged in Hand1ΔLV/ΔLV 
mutants compared with Hand1+/+ (p=0.01) and Hand1ΔLV/+ littermates (p=0.021). QT 
interval (D) is unaltered. Center lines - medians; box limits - 25th and 75th percentiles; 
whiskers - 1.5X the interquartile range from the box limits. Individual data points are 
represented by open circles outliers represented by closed circles. n = 18 wild-type, 19 
Hand1ΔLV/+, and 25 Hand1ΔLV/ΔLV mutants. E-G) Ventricular epicardial activation mapping 
in Langendorff-perfused hearts during right atrial pacing at a cycle length of 120 ms. 
Schematized atrial pacing (E) illustrates sites (blue dots 1 and 2) corresponding to the 
endocardial insertions of the Purkinje network branches. (F, G) Activation maps obtained 
from the anterior epicardial surfaces, with color-coded isochronal lines 1 ms apart. Time 
scales presented in ms, are to the right of the optical maps: dark blue, 0–5.7 ms; light blue to 
light green, 5.7 to 8.55 ms; green to light yellow 8.55 to 11.4 ms; light yellow to light orange 
11.4 to 14.25 ms; light orange to red 14.25 to 17.1 ms; red to dark red 17.1 to 20 ms. H) 
Differences in epicardial activation times (p=2X10−6) during atrial pacing between Hand1+/+ 
(white) and Hand1ΔLV/ΔLV (grey) hearts. I) RV epicardial breakthroughs, relative to the LV, 
in Hand1+/+ (n=8) and Hand1ΔLV/ΔLV (n=7) hearts (p=0.029). J) Schematized apical pacing 
showing to point of initial epicardial activation (blue). K and L) Isochronal activation maps 
obtained during direct ventricular pacing at a cycle length of 120 ms in the hearts 
respectively shown in (F) and (G) time scale identical to that of F and G. M) Epicardial 
activation times during apical pacing for the same hearts as in (H). p values calculated for B 
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and C employed one-way ANOVA followed by Tukey’s test for post hoc analyses. P values 
in H and I were calculated using Mann-Whitney Rank Sum test. All sample sizes indicate 
biological replicates.
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Figure 4. The Hand1 VCS expression domain is expanded in Hand1ΔLV mutants.
A, B) Whole mount X-gal staining of the Hand1lacZ allele shows X-gal expression in the 
postnatal (P42) LV septal wall (A, arrow). This staining is expanded in Hand1lacZ/ΔLV 
mutants (B). C, D) Coronal sections of Hand1lacZ/+ hearts, stained with X-gal (blue) in 
which the CCS has been labeled immunohistochemically with α-CNTN2 (brown), show 
partial co-localization of Hand1-reporter-positive cells to the His bundle (arrowhead) and 
left bundle branch (arrow).
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Figure 5. VCS hyperplasia in Hand1ΔLV/ΔLV mutants.
A-C) P7 hearts of Hand1ΔLV/ΔLV mutants bred onto a Cntn2IRES-Cre; R26RlacZ CCS 
reporter. The atria and great vessels have been removed, and the hearts have been stained in 
whole mount with X-gal and cleared. Hand1ΔLV/ΔLV;Cntn2+/IRES-Cre;R26R+/lacZ hearts (C; n 
= 7) displayed an increased number of X-gal-positive His bundle (arrowhead) and left 
bundle branch (arrow) cells, relative to Hand1+/+;Cntn2+/IRES-Cre;R26R+/lacZ (A) and 
Hand1+/ΔLV;Cntn2+/IRES-Cre;R26R+/lacZ hearts (B). D-G) P42, X-gal-stained 
Hand1ΔLV/ΔLV;Cntn2+/IRES-Cre;R26R+/lacZ hearts (E) display a hyperplastic His bundle 
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(arrowhead), and a significantly broader X-gal-positive staining domain overlapping with the 
LBB (arrow; n = 4/5), than Hand1+/+ controls (D). The peripheral portions of the RBB 
network (white arrowheads) in Hand1ΔLV/ΔLV;Cntn2+/IRES-Cre;R26R+/lacZ hearts (G) appear 
more compacted, and the proximal portions (white arrow) more spread out, and with more 
fascicles than Hand1+/+ controls (F; n = 3/5). Scale bars = 200 μM. H-K) 3D-reconstructions 
of HCN4 immunohistochemistry (red) upon sections of P0 hearts. Hand1ΔLV/ΔLV mutants (I, 
K) display abnormally dispersed, hyperplastic His bundles (white arrowheads) and left 
bundle branches (white arrows) compared with wild-type controls (H, J). Ventral views of 
the heart showing HCN4-positive cells with (H, I) and without (J, K) the surrounding 
myocardial cells (gray) are shown. All Scale bars = 200 μM. Sample sizes indicates 
biological replicates.
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Figure 6. Single Nucleotide Polymorphisms within the Human HAND1LV enhancer affect 
GATA4 binding, Hand1 expression, and VCS function.
A) Schematic representation of the human HAND1 locus illustrating the location of the five 
QRS-associated SNPs (orange) relative to the two critical GATA binding sites (green) within 
the conserved non-coding sequence (red). B) EMSA using lysate programmed with FLAG-
GATA4 demonstrates GATA4 binding (arrowhead) to radiolabeled oligonucleotides 
mimicking the major SNP variants of the human HAND1 sequence (WT). GATA4 does not 
bind as strongly to probes featuring the minor variant of rs10054375. The minor variant of 
rs10076436 does not impede GATA4 binding. Western blot for α-FLAG (inset) verifies 
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synthesis of FLAG-GATA4 added equally to each EMSA where indicated. + indicates the 
TnT lysate and the DNA probe represented in the gel shift lane. C) Schematic illustration of 
the minor SNP variants introduced into the Hand1+/36;75 mouse lines (highlighted in 
orange). A third, intervening nucleotide (denoted in charcoal) was mutated from G>A to 
block insertion-deletions. GATA binding site is highlighted in green. D) qRT-PCR of 
isolated E11.5 ventricles show reduced Hand1 gene expression in Hand136;75/36;75 hearts (n 
= 14) compared to wild-type controls (n = 18; p=0.039, according to a two-tailed students T-
Test and accompanying Benjamini-Hochberg false discovery rate). E-G, K-O) Epicardial 
activation maps obtained from Langendorff-perfused Hand136;75/36; 75 hearts (7–15 weeks; 
n=6) during right atrial pacing (pacing cycle length = 120 ms) displayed one (F) or three (G) 
epicardial breakthroughs, compared to 2 focused epicardial breakthroughs on the anterior 
walls of the right and left ventricle, characteristic of wild-type controls (E). Additional 
hearts (47–70 weeks; n=5) displayed two breakthrough points in the LV (K), a late (> 2 ms) 
breakthrough point in the RV (L, M), Two breakthroughs in the RV, one proximal to the apex 
and one diffuse and displaced toward the base (N), and a diffuse RV break-through 
misplaced toward base (O). H-J, P-T) Activation patterns are unaltered (Mann-Whitney U 
test) during direct ventricular pacing (cycle length = 120 ms) in Hand136;75/36;75 hearts 
compared with wild-type control. (Time scales presented in milliseconds (ms), are to the 
right of the optical maps: dark blue, 0–5.7 ms; light blue to light green, 5.7 to 8.55 ms; green 
to light yellow 8.55 to 11.4 ms; light yellow to light orange 11.4 to 14.25 ms; light orange to 
red 14.25 to 17.1 ms; red to dark red 17.1 to 20 ms. Sample sizes indicates biological 
replicates.
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Table 1.









Two breakthrough points in the LV 0 (0%) 0 (0%) 0 (0%) 1 (9.1%)
Single breakthrough point in the LV 0 (0%) 7 (46.7%) 0 (0%) 0 (0%)
Late (> 2 ms) breakthrough point in the 
RV 0 (0%) 4 (26.7%) 1 (33.3%) 2 (18.2%)
Single breakthrough point in the RV 0 (0%) 0 (0%) 0 (0%) 1 (9.1%)
Diffuse RV breakthrough misplaced 
toward base 0 (0%) 0 (0%) 0 (0%) 1 (9.1%)
Ectopic breakthrough proximal to the 
base of the LV 0 (0%) 2 (13.3%) 0 (0%) 0 (0%)
Two breakthroughs in the RV - one 
proximal to the apex and one diffuse and 
displaced toward the base
0 (0%) 0 (0%) 0 (0%) 1 (9.1%)
Two breakthroughs proximal to the apex 
of the LV, one in the RV 0 (0%) 1 (6.7%) 1 (33.3%) 1 (9.1%)
Late, ectopic breakthrough at the mid RV 0 (0%) 0 (0%) 1 (33.3%) 0 (0%)
Phenotypically Normal* 13 (100%) 1 (6.7%) 0 (0%) 4 (36.4%)
*
Two quasi-synchronous epicardial breakthroughs proximal to the apices of the LV and RV
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